MedPage Today on MSN
FDA warns of serious risks tied to misuse of double-chin fat dissolver
Neuromuscular, vision effects reported after Kybella injection outside submental fat regio ...
Citing what it called "newly identified risks," the FDA is reinforcing its warnings about adverse events associated with injections of deoxycholic acid (Kybella). In a drug safety communication ...
The FDA approved an additional warning in labeling, stating Kybella injection may cause neuromuscular and other serious adverse events with unapproved use, according to a drug safety communication ...
The US Food and Drug Administration (FDA) has approved an additional warning in labeling for Kybella (deoxycholic acid) ...
Please provide your email address to receive an email when new articles are posted on . The combination treatment decreased fat in the submental area and increased volume in the jawline. Submental ...
A US Food and Drug Administration (FDA) advisory committee unanimously voted today to recommend approval of a new injectable to help reduce double chin. The Dermatologic and Ophthalmic Drugs Advisory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results